A meta-analysis of the antiviral activity of the HBV-specific immunotherapeutic TG1050 confirms its value over a wide range of HBsAg levels in a persistent HBV pre-clinical model

por Kratzer, Roland, Sansas, Benoît, Lélu, Karine, Evlachev, Alexei, Schmitt, Doris, Silvestre, Nathalie, Inchauspé, Geneviève, Martin, Perrine
Publicado 2018

Single-Cell Analysis of Antigen-Specific CD8+ T-Cell Transcripts Reveals Profiles Specific to mRNA or Adjuvanted Protein Vaccines

por Meldgaard, Trine Sundebo, Blengio, Fabiola, Maffione, Denise, Sammicheli, Chiara, Tavarini, Simona, Nuti, Sandra, Kratzer, Roland, Medini, Duccio, Siena, Emilio, Bertholet, Sylvie
Publicado 2021

ZnT8 Is a Major CD8(+) T Cell–Recognized Autoantigen in Pediatric Type 1 Diabetes

por Énée, Émmanuelle, Kratzer, Roland, Arnoux, Jean-Baptiste, Barilleau, Emilie, Hamel, Yamina, Marchi, Christophe, Beltrand, Jacques, Michaud, Bénédicte, Chatenoud, Lucienne, Robert, Jean-Jacques, van Endert, Peter
Publicado 2012

Therapy of experimental type 1 diabetes by isolated Sertoli cell xenografts alone

por Fallarino, Francesca, Luca, Giovanni, Calvitti, Mario, Mancuso, Francesca, Nastruzzi, Claudio, Fioretti, Maria C., Grohmann, Ursula, Becchetti, Ennio, Burgevin, Anne, Kratzer, Roland, van Endert, Peter, Boon, Louis, Puccetti, Paolo, Calafiore, Riccardo
Publicado 2009

TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice

por Martin, Perrine, Dubois, Clarisse, Jacquier, Emilie, Dion, Sarah, Mancini-Bourgine, Maryline, Godon, Ophélie, Kratzer, Roland, Lelu-Santolaria, Karine, Evlachev, Alexei, Meritet, Jean-François, Schlesinger, Yasmin, Villeval, Dominique, Strub, Jean-Marc, Van Dorsselaer, Alain, Marchand, Jean-Baptiste, Geist, Michel, Brandely, Renée, Findeli, Annie, Boukhebza, Houda, Menguy, Thierry, Silvestre, Nathalie, Michel, Marie-Louise, Inchauspé, Geneviève
Publicado 2015